- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 18:46 | AbbVie tries to reassure investors on Humira biosimilar threat | ||
| 17:46 | Pfizer hemophilia gene therapy arrives in US to uncertain future | ||
| Do | AstraZeneca's earnings surprise investors as cancer drugs fuel growth | ||
| Do | BioMarin drops drug programs in pipeline cull | ||
| Do | Bristol Myers to cut 6% of workforce, trim drug pipeline | ||
| Do | Regeneron expands in gene editing with Mammoth deal | ||
| Mi | Biogen: Don't expect any big acquisitions this year | ||
| Mi | Moderna turns to AI to change how its employees work | ||
| Mi | Biogen sees 'encouraging' trends for postpartum depression drug | ||
| Mi | Biogen to invest more in launch of Alzheimer's drug Leqembi | ||
| Mi | [Podcast] Partner for Progress: Strategies for Biotech Success | ||
| Mi | CureVac to cut costs in restructuring | ||
| Mi | Endeavor pulls in $132M to back cancer, lung disease drugs | ||
| Di | Former Bristol Myers CEO tapped as Novartis' next board chair | ||
| Di | Novartis raises forecasts as top drug sales beat Wall Street estimates | ||
| Di | Neurocrine scores surprise win with depression drug | ||
| Di | FDA rejects Abeona cell therapy, asks for more manufacturing data | ||
| Di | Lilly to buy injectable drug plant in manufacturing ramp-up | ||
| Mo | Ipsen, Skyhawk to develop RNA-targeting pills for rare brain diseases | ||
| Mo | Eisai hunts for next Alzheimer's drug with new research pact | ||
| Mo | Bristol Myers taps startup to boost cell therapy production | ||
| Mo | Pharmas form joint venture to jumpstart Japanese drug research | ||
| Mo | How can pharma speed time to treatment? Digital tools can help | ||
| 19.04. | Alvotech deal could heighten biosimilar pressure on Humira | ||
| 19.04. | Roche wins FDA OK for targeted drug in early lung cancer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
